Flagship Pioneering as of Dec. 31, 2022
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 12 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 73.9 | $2.3B | 13M | 179.62 | |
| Omega Therapeutics (OMGAQ) | 9.4 | $294M | 26M | 11.33 | |
| Sana Biotechnology (SANA) | 4.3 | $135M | 34M | 3.95 | |
| Seres Therapeutics | 4.1 | $130M | 23M | 5.60 | |
| Evelo Biosciences | 2.6 | $81M | 50M | 1.61 | |
| Foghorn Therapeutics (FHTX) | 2.6 | $81M | 13M | 6.38 | |
| Denali Therapeutics (DNLI) | 2.3 | $73M | 2.6M | 27.81 | |
| Axcella Health Inc equity | 0.3 | $9.4M | 29M | 0.32 | |
| Rubius Therapeutics | 0.2 | $6.5M | 39M | 0.17 | |
| Sigilon Therapeutics | 0.1 | $3.6M | 10M | 0.35 | |
| Syros Pharmaceuticals (SYRS) | 0.1 | $3.6M | 994k | 3.59 | |
| Codiak Biosciences | 0.0 | $1.4M | 3.5M | 0.39 |
